SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john robinson who wrote (53)8/22/1997 10:49:00 PM
From: John McCarthy   of 569
 
John,

I have been following BIOX for about 2 years. The quick FDA approval
was a surprize to me. I have a few questions that you, or others, may have an insight into.

(1) The deal with AHP was $23.0 mil.

They booked $4.0 mil in the last qtr.

They said they were getting another $12.0 mil. because of the
approval.

That leaves $7.0 mil. unspoken for. To steal a line -
Where's the money? Do you know what the terms are for
the balance.

(2) Finally, NO ONE is talking about China. But, a billion folks
is a billion folks.

If AHP paid $23.0 mil for USA and parts of Europe/Asia,
what's China worth? I have to believe that Bayer, who as
I'm sure you know, has already bought into some of the
Asian Rim countries, must be eyeing this. But I don't know
how large their sales force is out there.

I think China is worth $25.0 mil. to $35.0 mil.

Any thoughts on this?

Regards,

John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext